SUBSCRIBE

Breaking News on Global Pharmaceutical Technology & Manufacturing

Capsugel completes $25m SDD expansion at Bend site

02-Jul-2015 - Capsugel has pledged to continue investing internally in drug delivery R&D after completing construction of a spray-dried dispersion (SDD) commercial manufacturing site in Oregon.

Juniper to make OxSonics' ultrasound particles to aid cancer drug delivery

30-Jun-2015 - Juniper Pharma Services has won a contract to manufacture ‘sono-sensitive particles’ used to aid delivery of cancer drugs into solid tumours for OxSonics.

Teva pays $35m upfront for implantable drug delivery device partnership

30-Jun-2015 - Generic juggernaut Teva Pharmaceuticals has partnered with Microchips Biotech to use its implantable drug delivery device to improve outcomes for patients on chronic drug therapies.

Chin up: Allergan looks to fat-busting drug with $2.1bn Kythera deal

29-Jun-2015 - Allergan is set to acquire Kythera Biopharmaceuticals for $2.1bn (€1.9bn) and add the recently approved injectable ‘double-chin’ drug Kybella to its facial aesthetics portfolio.

Phos enzyme ID'd using CRISPR may lead to safer cancer meds say researchers

19-Jun-2015 - A newly identified enzyme that modifies secreted proteins could lead to safer cancer drugs and new osteoporosis treatments say scientists.

Biocorp plans IPO to win more Big Pharma device contracts

16-Jun-2015 - Delivery device maker Biocorp has announced plans to go public and list of Paris’ Alternext market as part of an effort to win more Big Pharma deals.

New drug delivery technologies seek to advance personalized oncology treatments

11-Jun-2015 - Ongoing research on two new drug delivery systems could help clinicians more accurately understand how certain tumors react to different treatments, according to the Journal of the American Medical Association .

CSIRO tells of sea shells that protect sensitive cures

09-Jun-2015 - A capsule inspired by the porous structure of seashells has been developed to protect drugs from extreme temperatures and could be used in controlled delivery.

GSK breathes freely as Mylan launches Seretide generic in UK

08-Jun-2015 - GlaxoSmithKline is unconcerned about losing its position in the respiratory market as Mylan launches the first generic version of blockbuster asthma product Seretide in the UK.

MannKind: Social media buzz will propel Afrezza to blockbuster status

04-Jun-2015 - MannKind’s CFO has no doubt Afrezza will be a blockbuster despite a slow start since launch and is adjusting its manufacturing network in preparation.

Bubble delivery can rescue failing drug candidates, says Oxford team

02-Jun-2015 - University of Oxford scientists are saving undeliverable drugs by placing them in gas bubbles for better bioavailability and fewer side effects.

Afrezza's launch a boost for alternate insulin delivery R&D, says Oramed

02-Jun-2015 - There is still demand for alternative to injection for insulin despite the subdued launch of Sanofi’s Afrezza, Oramed says as it pushes forward with its oral candidate.

3D printed scaffold could free diabetic cell transplant recipients from immunosupressive meds

28-May-2015 - Dutch scientists have used 3D printing to produce a protective scaffold that could make cell transplant-based diabetes treatment more successful and eliminate the need for immunosupressive drugs.

Novartis to assess biologics with micro-sugar-needle delivery tech

27-May-2015 - Novartis has partnered with Google-backed Rani Therapeutics to assess an oral platform which delivers biologics through the intestinal wall using needles made of sugar.

Inhalable biologics: Serendex formulates with Novozymes’ Recombumin

20-May-2015 - Serendex Pharmaceutical is a step closer to developing an inhalable biopharmaceutical for lung disease after adopting stabilising tech from Novozymes.

Cancer-hunting shark proteins are the future of drug conjugation, says Almac

19-May-2015 - Almac is coupling tiny shark proteins to a cancer-killing warhead to develop an oncology drug, saying their small size makes for easy conjugation. 

Perrigo enters softgel space buying ex-Banner operations for $34m from Patheon

13-May-2015 - Patheon has sold its Mexican operations to Perrigo for $34m as it looks to transform the Banner business it acquired back in 2012.

EMA: clinical data may not be needed for topical comparisons

13-May-2015 - The EMA (European Medicines Agency) is changing the way it assesses quality of topical drugs for marketing authorisations.

Lilly builds drug delivery and device R&D site

12-May-2015 - Eli Lilly is building a drug delivery and device innovation centre in Cambridge, Massachusetts.

MannKind: Afrezza's slow start due to delays not demand for inhalable insulin

12-May-2015 - Sanofi's inhaled insulin drug Affrezza has generated lower than expected revenue due to marketing delays rather than low demand according to MannKind CFO, Matthew Pfeffer.

Catalent's oral Zydis tech: a hard pill for injectable vaccine makers?

07-May-2015 - Vaccines being developed using Catalent's oral Zydis platform would increase compliance and cut costs but Big Pharma is slow to get on board, the firm says.

Capsugel focusing on inhaled biotherapeutics from Bend facility

06-May-2015 - Capsugel says it is bolstering its service to offer specialised dry powder inhalation (DPI) formulations, allowing biotherapeutics to be delivered to the lung rather than by injection.

Controlled-release tech turns liquid drugs solid in stomach

04-May-2015 - A liquid-gel which solidifies in the stomach could offer drugmakers an effective modified-release delivery option, according to the lead scientist behind the project.

Catalent and 3M stress the importance of being bioavailable

30-Apr-2015 - [View the story "Bracknell hosts earnest drug delivery tech discussion" on Storify]

Recipharm in talks to make LIDDS' prostate cancer drug-device candidate

22-Apr-2015 - Recipharm has begun negotiations to manufacture a prostate cancer drug-device candidate for Swedish pharma firm LIDDS.

Key Industry Events

 

Access all events listing

Our events, Shows & Conferences...